{"id":"NCT00268892","sponsor":"Ferring Pharmaceuticals","briefTitle":"Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer","officialTitle":"An Open-Label, Multi-Centre, Extension Study, Evaluating the Long-Term Safety and Tolerability of Different Three-Month Degarelix Dosing Regimens in Patients With Prostate Cancer","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2006-01","primaryCompletion":"2009-09","completion":"2009-12","firstPosted":"2005-12-23","resultsPosted":"2010-12-06","lastUpdate":"2010-12-24"},"enrollment":278,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer"],"interventions":[{"type":"DRUG","name":"Degarelix","otherNames":["FE200486"]},{"type":"DRUG","name":"Degarelix","otherNames":["FE200486"]},{"type":"DRUG","name":"Degarelix","otherNames":["FE200486"]}],"arms":[{"label":"Degarelix 240/240@40(1-3-6-9)","type":"EXPERIMENTAL"},{"label":"Degarelix 240/240@60(1-3-6-9)","type":"EXPERIMENTAL"},{"label":"Degarelix 240/240@60(1-4-7-10)","type":"EXPERIMENTAL"}],"summary":"The purpose of this extension study was to collect long-term safety and tolerability information to support a marketing authorisation application for a three-month dosage regimen of degarelix.","primaryOutcome":{"measure":"Number of Participants With Markedly Abnormal Values in Vital Signs and Body Weight","timeFrame":"Baseline and up to 4.5 years","effectByArm":[{"arm":"Degarelix 240/240@40(1-3-6-9)","deltaMin":5,"sd":null},{"arm":"Degarelix 240/240@60(1-3-6-9)","deltaMin":6,"sd":null},{"arm":"Degarelix 240/240@60(1-4-7-10)","deltaMin":4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":23,"countries":["Belgium","Finland","France","Germany","Montenegro","Netherlands","Romania","Russia","Serbia","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":30,"n":90},"commonTop":["Hot Flush","Injection Site Pain","Injection Site Erythema","Pyrexia","Fatigue"]}}